atorvastatin has been researched along with Urinary Bladder Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeong, CW; Kang, M; Kim, HH; Ku, JH; Kwak, C | 1 |
| Flemington, V; Ganley, IG; King, MA | 1 |
| Al-Tantawy, SM; El-Ashmawy, NE; El-Bahrawy, HA; Khedr, EG | 1 |
| Figueiredo, A; Mota, A; Neto, P; Parada, B; Pinto, Â; Reis, F; Rocha-Pereira, P; Sereno, J; Teixeira, F; Xavier-Cunha, M | 1 |
| Kamat, AM; Nelkin, GM | 1 |
5 other study(ies) available for atorvastatin and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Inhibition of autophagy potentiates atorvastatin-induced apoptotic cell death in human bladder cancer cells in vitro.
Topics: Anticholesteremic Agents; Antineoplastic Agents; Apoptosis; Atorvastatin; Autophagy; Cell Line, Tumor; Heptanoic Acids; Humans; Pyrroles; Urinary Bladder; Urinary Bladder Neoplasms | 2014 |
Inhibition of cholesterol metabolism underlies synergy between mTOR pathway inhibition and chloroquine in bladder cancer cells.
Topics: Atorvastatin; Autophagy; Cell Line, Tumor; Cell Membrane Permeability; Chloroquine; Cholesterol; Drug Synergism; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lysosomes; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Receptors, Fibroblast Growth Factor; Signal Transduction; TOR Serine-Threonine Kinases; Urinary Bladder Neoplasms | 2016 |
Chemopreventive effect of omega-3 polyunsaturated fatty acids and atorvastatin in rats with bladder cancer.
Topics: Animals; Apoptosis; Atorvastatin; Butylhydroxybutylnitrosamine; Cell Proliferation; Docosahexaenoic Acids; Eicosapentaenoic Acid; Male; Oxidative Stress; Random Allocation; Rats; Urinary Bladder Neoplasms | 2017 |
Chemopreventive efficacy of Atorvastatin against nitrosamine-induced rat bladder cancer: antioxidant, anti-proliferative and anti-inflammatory properties.
Topics: Animals; Anti-Inflammatory Agents; Anticarcinogenic Agents; Antioxidants; Atorvastatin; Biomarkers, Tumor; Butylhydroxybutylnitrosamine; Cell Proliferation; Drug Evaluation, Preclinical; Heptanoic Acids; Male; Oxidative Stress; Pyrroles; Rats, Wistar; Urinary Bladder; Urinary Bladder Neoplasms | 2012 |
Atorvastatin: a potential chemopreventive agent in bladder cancer.
Topics: Atorvastatin; Carcinoma, Transitional Cell; Cell Line, Tumor; Drug Screening Assays, Antitumor; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Urinary Bladder Neoplasms | 2005 |